Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

The United States Cutaneous Lymphoma Consortium is a multidisciplinary society of physicians which use collaborative research and education to improve the quality of life and prognosis of patients ...

A new study showed that psoriasis patients were 1.68 times more likely to acquire onychomycosis than people without psoriasis ...

Onychomycosis Treatment MarketThe global onychomycosis treatment market is projected to grow from USD 4,738.3 million in 2023 to USD 10,608.8 million by 2033, exhibiting a robust CAGR of 8.4% during ...

SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Presentation Highlights HyBryte Potential in CTCL In January 2025, Dr ...

CTCL accounts for approximately 4% of all non-Hodgkin’s lymphomas and has a median age at diagnosis of 55-65 years. Mycosis fungoides, and Sézary syndrome, its leukemic variant, are the most common ...

Valley fever is a fungal lung infection that occurs when you inhale spores from Coccidioides immitis or Coccidioides posadaii. The disease is also called coccidioidomycosis. Symptoms include cough, ...

A psychological horror story set in rural Wales amid the mysterious world of mycelium. A psychological horror story set in rural Wales amid the mysterious world of mycelium. A psychological horror ...

Symptom control is often the goal for patients who have mycosis fungoides, the most common type of cutaneous T-cell lymphoma. Mycosis fungoides tends to advance slowly, so symptom control can help you ...

Background: Cutaneous T-cell lymphoma (CTCL) is a heterogeneous group of T-cell lymphomas characterized with the presence of clonal malignant T cells. Mycosis fungoides (MF) is the most common type of ...